Publication:
Use of human pluripotent stem cell-derived cells for neurodegenerative disease modeling and drug screening platform.

dc.contributor.authorGarcia-Leon, Juan Antonio
dc.contributor.authorVitorica, Javier
dc.contributor.authorGutierrez, Antonia
dc.date.accessioned2023-01-25T13:34:31Z
dc.date.available2023-01-25T13:34:31Z
dc.date.issued2019-06-04
dc.description.abstractMost neurodegenerative diseases are characterized by a complex and mostly still unresolved pathology. This fact, together with the lack of reliable disease models, has precluded the development of effective therapies counteracting the disease progression. The advent of human pluripotent stem cells has revolutionized the field allowing the generation of disease-relevant neural cell types that can be used for disease modeling, drug screening and, possibly, cell transplantation purposes. In this Review, we discuss the applications of human pluripotent stem cells, the development of efficient protocols for the derivation of the different neural cells and their applicability for robust in vitro disease modeling and drug screening platforms for most common neurodegenerative conditions.
dc.identifier.doi10.4155/fmc-2018-0520
dc.identifier.essn1756-8927
dc.identifier.pmid31161803
dc.identifier.unpaywallURLhttps://www.future-science.com/doi/pdf/10.4155/fmc-2018-0520
dc.identifier.urihttp://hdl.handle.net/10668/14074
dc.issue.number11
dc.journal.titleFuture medicinal chemistry
dc.journal.titleabbreviationFuture Med Chem
dc.language.isoen
dc.organizationInstituto de Investigación Biomédica de Málaga-IBIMA
dc.organizationInstituto de Biomedicina de Sevilla-IBIS
dc.organizationHospital Universitario Virgen del Rocío
dc.page.number1305-1322
dc.pubmedtypeJournal Article
dc.pubmedtypeResearch Support, Non-U.S. Gov't
dc.pubmedtypeReview
dc.rightsAttribution-NonCommercial-NoDerivatives 4.0 International
dc.rights.accessRightsopen access
dc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/4.0/
dc.subjectAlzheimer’s disease
dc.subjectCRISPR-Cas9
dc.subjectHuntington’s disease
dc.subjectParkinson’s disease
dc.subjectamyotrophic lateral sclerosis
dc.subjectdisease modeling
dc.subjectdrug screening
dc.subjecthiPSCs
dc.subjecthuman-induced pluripotent stem cells
dc.subjectmultiple sclerosis
dc.subjectneurodegenerative disease
dc.subject.meshAnimals
dc.subject.meshCRISPR-Cas Systems
dc.subject.meshDrug Evaluation, Preclinical
dc.subject.meshGene Editing
dc.subject.meshHumans
dc.subject.meshNeurodegenerative Diseases
dc.subject.meshNeurogenesis
dc.subject.meshNeurons
dc.subject.meshPluripotent Stem Cells
dc.titleUse of human pluripotent stem cell-derived cells for neurodegenerative disease modeling and drug screening platform.
dc.typeresearch article
dc.type.hasVersionVoR
dc.volume.number11
dspace.entity.typePublication

Files